Sign Up Today and Learn More About TMRW Life Sciences Stock
Invest in or calculate the value of your shares in TMRW Life Sciences or other pre-IPO companies through EquityZen's platform.
TMRW Life Sciences Stock (TMLS)
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
About TMRW Life Sciences Stock
Founded
2018
Headquarters
New York, NY, US
Industries
Software, Science and Engineering, Health Care
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.
TMRW Life Sciences Press Mentions
Stay in the know about the latest news on TMRW Life Sciences
TMRW Life Sciences Raises $28M Series D Financing
finsmes • Sep 20, 2024
SoHo biotech raises $28M to safeguard and track embryos for IVF
crainsnewyork • Aug 03, 2024
TMRW Life Sciences: Automated Specimen Management Company Secures Over $28 Million In Series D
pulse2 • Jul 27, 2024
Exclusive: TMRW Life Sciences raises $28M Series D to upgrade storage for egg freezing
endpts • Jul 18, 2024
TMRW Life Sciences Expands Network of State-of-the-Art Cryostorage Facilities for Frozen Sperm, Eggs and Embryos ...
prnewswire • Jul 05, 2024
TMRW Life Sciences Management
Leadership team at TMRW Life Sciences
Founder & Co-CEO
Joshua Abram
Board Member
Emily Drabant Conley
Join now and verify your accreditation status to gain access to:
- TMRW Life Sciences current valuation
- TMRW Life Sciences stock price
- Available deals in TMRW Life Sciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading TMRW Life Sciences Stock
How to invest in TMRW Life Sciences stock?
Accredited investors can buy pre-IPO stock in companies like TMRW Life Sciences through EquityZen funds. These investments are made available by existing TMRW Life Sciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell TMRW Life Sciences stock?
Shareholders can sell their TMRW Life Sciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
